Dacomitinib is an oral, irreversible tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR) family, indicated for the treatment of specific forms of non-small cell lung cancer (NSCLC).… Read more



















Dacomitinib is an oral, irreversible tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR) family, indicated for the treatment of specific forms of non-small cell lung cancer (NSCLC). To support rigorous analytical testing, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, process-related impurities, and degradation products such as desmethyl and nitroso derivatives. Pharmaceutical laboratories utilize these materials for impurity profiling, method development, and validation to ensure product safety and compliance. Furthermore, stable isotope labelled compounds are available to serve as high-quality internal standards for mass spectrometry-based assays, enabling precise quantitation in complex biological matrices. By offering these critical reference materials, the collection facilitates accurate quality control and stability assessment throughout the drug development and manufacturing lifecycle of this kinase inhibitor.